MedTrace Logo

MDR Bacilli Surveillance and Clinical Feature in China

NCT02140853 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2014-05-16

No results posted yet for this study

Summary

Objective

1. To evaluate the impact of MDR pathogen on prognosis and therapy cost;
2. To compare the efficacy of different antibiotics in treatment of infection caused by MDR pathogens;
3. To evaluate the risk factors of MDR pathogens infection;
4. To evaluate the distribution and characteristics of MDR pathogens;
5. To investigate the proportion of MDR isolates to construct systematic database.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Canmao Xie, MD · Sun Yat-sen University

  • Yuxing Ni, MD · Ruijin Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02140853 on ClinicalTrials.gov